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Available online 19 January 2016Increased binge alcohol consumption has been reported among adolescents as compared to adults in both
humans and rodent models, and has been associated with serious long-term health consequences. However,
the neurochemical mechanism for age differences in binge drinking between adolescents and adults has not
been established. The present studywas designed to evaluate themechanistic role of the cannabinoid CB1 recep-
tor in adolescent and adult binge drinking. Binge consumption was established in adolescent and adult male
C57BL/6J mice by providing access to 20% alcohol or 1% sucrose for 4 h every other day. Pretreatment with the
CB1 antagonist/inverse agonist AM-251 (0, 1, 3, and 10 mg/kg) in a Latin square design dose-dependently
reduced adolescent alcohol consumption to adult levels without altering adult intake. AM-251 (3mg/kg) also re-
duced adolescent but not adult sucrose consumption. Adolescent reductions in alcohol and sucrose were not as-
sociated with alterations in open-ﬁeld locomotor activity or thigmotaxis. These ﬁndings point to age differences
in CB1 receptor activity as a functional mediator of adolescent-typical increased binge drinking as compared to
adults. Developmental alterations in endocannabinoid signaling in the adolescent brainmay therefore be respon-
sible for the drinking phenotype seen in this age group.







Adolescence, or the period between childhood and adulthood, is an
evolutionarily conserved developmental period characterized by physi-
cal and behavioral changes as organismsmature. Drug use is commonly
initiated during adolescence, perhaps due to the increased risk-taking,
novelty-seeking and impulsive behaviors exhibited by this vulnerable
age group (Crews et al., 2007; Spear, 2000). Likemost drugs of abuse, al-
cohol use is usually initiated in adolescence (Johnston et al., 2012), and
adolescent consumption of alcohol has been associatedwith greater risk
of alcoholismover the lifespan (Dawson et al., 2008). In particular, binge
drinking is more frequently reported in adolescent than adult popula-
tions (Nelson et al., 2009) and is associated with several long-term neg-
ative health consequences, including increased risk for thedevelopment
of alcohol use disorders (Courtney and Polich, 2009). However, the neu-
robiological differences between the adolescent and adult brain that
may be responsible for behavioral differences and contribute to adoles-
cent drug use and abuse have not yet been fully characterized.
During adolescence, signiﬁcant changes in brain structure, receptor
density and neurotransmitter levels occur as the brain matures. Inhol Studies, Thurston-Bowlesparticular, the endocannabinoid signaling systems undergoes signiﬁcant
structural and functional changes during adolescence in both humans
and rodent models. In the human dorsal-lateral prefrontal cortex, CB1
mRNA peaks during childhood and remains high until adolescence,
when it decreases to adult levels (Long et al., 2012). Similar patterns
have been observed in the rat cortex with CB1 protein (Ellgren et al.,
2008; Rodriguez de Fonseca et al., 1993) and mRNA (Heng et al., 2011;
Van Waes et al., 2012). The endogenous ligands for the CB1 receptor,
anandamide (AEA) and 2-arachidonoylglycerol (2-Ag), also experience
signiﬁcant ﬂux during adolescent development, as do many of the en-
zymes responsible for their synthesis and degradation (Ellgren et al.,
2008; Lee et al., 2013; Rubino et al., 2015; Wenger et al., 2002). These al-
terations in the endocannabinoid systems of the adolescent brain have a
net effect of increasing CB1 inhibition of synaptic activity in juveniles
and disinhibiting cortical output as the brain matures into adulthood
(Heng et al., 2011). Decreased cortical control of sensorimotor brain re-
gions has been associated with lack of inhibitory control over behavior,
a behavioral characteristic of adolescence. Indeed, the cannabinoid sys-
tems have been shown to play a role in adolescent-typical behaviors. In-
teraction with a non-familiar social partner increases AEA levels in the
adolescent rat brain (Marco et al., 2011), and inhibiting the degradation
of AEA in the adolescent brain enhances social play behavior (Trezza
et al., 2012). Inhibiting AEA degradation also reduces impulsive
responding in an intolerance-to-delay task among maternally deprived
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hanced activity of the CB1 receptor in adult rats creates adolescent-typical
behavioral phenotypes, including increased novelty seeking, social inter-
action, impulsivity, and sensitivity to the rewarding effects of cocaine
(Schneider et al., 2015). Additionally, in a human adolescent sample poly-
morphisms in theCNR1 gene,which encodes the CB1 receptor,were asso-
ciated with self-reported impulsive behavior (Buchmann et al., 2015).
Thus, the endocannabinoid systems undergo signiﬁcant developmental
regulation during adolescence, and may be involved in adolescent-
typical behaviors that contribute to increased risk for drug use and abuse.
In studieswith adult rodents and humans, a role for cannabinoid sig-
naling in alcohol use and abuse has also been established. Acute alcohol
exposure reduces CB1 receptor expression in the adult mouse brain
(Basavarajappa et al., 1998) and increases AEA and 2-AG concentrations
in vitro (Basavarajappa andHungund, 1999; Basavarajappa et al., 2008).
CB1 receptor availability has also been shown to decrease in the cortex
of human alcoholics (Ceccarini et al., 2014), and SNPs in the human
CNR1 gene have been associated with alcoholism (Schmidt et al.,
2002).Modulation of CB1 signalinghas been shown to alter alcohol con-
sumption in adult rodents. Pharmacological activation of CB1 has gener-
ally produced increases in alcohol self-administration (Alen et al., 2009;
Linsenbardt and Boehm, 2009; Vinod et al., 2008) whereas pharmaco-
logical inactivation (Cippitelli et al., 2005; Vinod et al., 2008) andgenetic
deletion (Lallemand and deWitte, 2005; Racz et al., 2003) of the CB1 re-
ceptor has led to decreased alcohol intake and preference in adults (see
Pava &Woodward, 2012 for review). These studies establish the CB1 re-
ceptor as both a target of alcohol's activity in the adult brain as well as a
functional modulator of alcohol consumption in rodents.
Developmental differences in the effects of cannabinoid signaling on
alcohol intake have received limited investigation to date. Wang et al.
(2003) compared young adult (post-natal day 42–70) and older adult
(PND 182–336) CB1 knockout and wild type mice for alcohol intake
and preference. Young adult CB1 knockout mice showed reduced alco-
hol preference and a trend for reduced intake (dose) as compared to
wild type controls,whereas older adult CB1 knockoutmicewere not dif-
ferent than wild type. These results suggest that some of the regulation
of alcohol consumption by CB1 activity may be age-dependent, al-
though the study did not directly compare adolescent to adult mice.
One additional study has also demonstrated that the CB1 agonist WIN
55,212-2 increased anxiety-related behaviors and increased 24-hour
ethanol consumption in adolescent but not adult rats (Klugmann
et al., 2011). These studies provide preliminary evidence that develop-
mental stage may be a factor in cannabinoid-mediated alcohol con-
sumption, but more work is needed to establish a functional role for
cannabinoid regulation of adolescent alcohol consumption.
The current studies were designed to examine the effects of CB1 re-
ceptor inhibition on alcohol consumption in adolescent and adult male
C57BL/6J mice, an inbred mouse strain that has been shown to consume
alcohol in a binge-like manner and achieve intoxicating doses in binge
models (Agoglia et al., 2015; Holstein et al., 2011). We utilized a model
of binge-like alcohol consumption in order to reﬂect the pattern of drink-
ing behavior most commonly reported by adolescents in the clinical liter-
ature (Courtney and Polich, 2009;Miller et al., 2007). The CB1 antagonist/
inverse agonist AM-251 was used to inhibit activity of the CB1 receptor.
Additionally, we examined effects of this compound on locomotor activi-
ty, anxiety-like behavior, and consumption of the non-drug reinforcer su-
crose. Our ﬁndings provide new evidence for developmental differences
in sensitivity to pharmacological blockade of CB1 receptor activity, both
in binge-like alcohol consumption and related behaviors.
2. Methods
2.1. Subjects
All animal procedures were carried out in accordance with the NIH
Guide to Care and Use of Laboratory Animals (NRC, 2011) and approvedby the Internal Review Board of the University of North Carolina, Chapel
Hill. Male adolescent (postnatal day [PND] 21) and adult (PND 63 ± 2)
C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were housed in
standard cages with a small PVC pipe for environmental enrichment.
Mice were singly housed to measure individual alcohol intake, consis-
tent with previous studies (Rhodes et al., 2005; Thiele et al., 2014).
Food and water were available ad libitum in home cages except where
noted. The colony room was maintained on a 12-h light/dark cycle
(lights on at 20:00) at 21 °C. All experimental manipulations and testing
occurred during the dark cycle.
2.2. Drugs
Alcohol drinking solutions (v/v) were prepared by diluting 95% eth-
anol (Pharmco Products Inc., Brookﬁeld, CT) with water. Sucrose drink-
ing solutions (w/v) were prepared by dissolving sucrose in water. The
CB1 antagonist/inverse agonist AM-251 (Tocris Bioscience; Ellisville,
MO) was suspended in 25% β-cyclodextrin (Sigma-Aldrich, St. Louis,
MO) and injected in doses of 0, 1.0, 3.0 and 10.0 mg/kg i.p. with a
30 min pretreatment time. All drug solutions were freshly prepared
each day of testing.
2.3. Binge drinking procedure
Binge drinking was established in mice as previously described
(Agoglia et al., 2015; Holstein et al., 2011). All subjects (N = 36) were
given one week upon arrival (on experimental day 0, see Fig. 1) at our
facility to acclimate to our colony environment. During acclimation, ha-
bituation injections were administered on experimental days 4 and 6.
On experimental day 7, beginning 3 h into the dark cycle (10:00 AM)
on PND 28 (adolescent) and 72 (adult), home cage water bottles were
removed and replaced with a double ball-bearing drinking tube con-
taining 20% (v/v) ethanol (n = 12/age) or 1% (w/v) sucrose (n = 6/
age) respectively in each experiment. Drinking tubes were removed
after 2 h of access at 12:00 PM and ﬂuid consumption was recorded. Al-
cohol accesswas restricted to 2 h on theﬁrst day of drinking to avoid ex-
cessive intake that might lead to aversive effects which could limit
subsequent alcohol drinking. The following day (experimental day 8),
habituation injections were again administered. On experimental day
9, tubes were again placed on home cages at 10:00 AM and left in
place for 4 h with removal at 2:00 PM. Mice had access to the tubes
for 4 h a day, every other day, for the remainder of the experiments
(Fig. 1.) Additional habituation injections were administered on an ad-
ditional non-drinking day (experimental day 10) as well as 30 min be-
fore tube access on the two drinking days prior to drug testing
(experimental days 11 and 13) for a total of six days of habituation in-
jections in all, two on drinking days and four on non-drinking days.
Beginning on PND 36/80, each drinking session was preceded by an
injection of AM-251or vehicle. The alcohol drinking experiment utilized
a Latin square design to test four doses of AM-251 (0, 1.0, 3.0 and
10.0 mg/kg) within subjects. The sucrose drinking experiments tested
the lowest effective dose of AM-251 in the alcohol experiment
(3.0 mg/kg) in a between-subjects design.
2.4. Locomotor testing
Following the completion of alcohol drinking, on PND 44 (adoles-
cent) or PND 88 (adult) mice were injected with either vehicle or AM-
251 (1 mg/kg, 30-min pretreatment) prior to a locomotor activity test
(n = 6/treatment/age). Open ﬁeld activity was measured in Plexiglas
activity monitor chambers (27.9 cm2; ENV-510, Med Associates,
Georgia, VT) connected to computers for data collection (Hodge et al.,
1999; Stevenson et al., 2008). Two sets of 16 pulse-modulated infrared
photobeamswere located on opposite walls and recorded X–Y ambula-
tory movements. The mouse's position in the open ﬁeld was assessed
every 100 ms to quantify distance traveled (in meters).
Fig. 1. Timeline of adolescent and adult drinking. (A) Binge-like alcohol drinking. (B) Binge-like sucrose drinking. Each box represents one day. Top numbering describes the experimental
day of each phase of the experiment, and bottomnumbering describes the age of adolescent and adultmice in post-natal days (PND) at each time point during the experiment. Gray boxes
marked “A” indicate alcohol drinking days and “S” indicate sucrose drinking days, respectively. Unﬁlled arrows indicate habituation vehicle injections, solid arrows indicate drinking
sessions preceded by a drug injection.
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Alcohol intake data were reported as grams of alcohol per kilogram
of body weight and sucrose intake data were reported as milliliters of
ﬂuid consumed per kilogram of body weight. One adolescent mouse
in the alcohol drinking experiment was excluded from the analysis
due to consistently low levels of alcohol intake (b1 g/kg in 4 h). Alcohol
intake data were analyzed via two-way repeated measures ANOVA
(Age × Dose) with one-way repeated measures ANOVA separately
within age groups as planned comparisons. Holm–Sidak's multiple
comparisons test was used for all post-hoc analyses. Sucrose intake
was analyzed via Student's t-test. Open ﬁeld locomotor data were col-
lapsed into 20 min time bins and activity was assessed via two-way
repeated measures ANOVA (Dose × Time) separately within each age.
Locomotor data were further analyzed for potential age or drug-
induced differences in anxiety-like behavior in an open-ﬁeld test.
Thigmotaxis was evaluated by comparing distance (cm) traveled in
the center zone (inner 25% of the area) to distance traveled in the pe-
riphery (outer 75% of the area) as previously described (Agoglia et al.,
2015; Hodge et al., 2002).αwas set at 0.05 for all comparisons. All anal-
yses were performed using Prism v. 6.0 (GraphPad, La Jolla, CA).Table 1
Baseline alcohol intake in adolescent and adult mice. Mean alcohol consumption in grams
of alcohol per kilogram of bodyweight (±SEM) of adolescent and adult mice on the three
drinking days prior to drug testing. No Inj. indicates drinking days without injections, and
Hab. Inj. indicates drinking days preceded by habituation injections.
Alcohol Intake (g/kg)
Age Day 9 (No Inj.) Day 11 (Hab. Inj.) Day 13 (Hab. Inj.)
Adolescent 3.60±0.46 3.80±0.51 4.11±0.35
Adult 4.27±0.38 4.36±0.31 4.67±0.283. Results
3.1. Baseline drinking and body weight
Adolescent alcohol consumption averaged 3.88 g/kg and adult in-
take averaged 3.99 g/kg over the four-hour drinking session prior to
drug testing (Table 1). Sucrose consumption averaged 97.64 mL/kg in
adolescents and 82.71 mL/kg in adults. No signiﬁcant age differences
in consumption prior to drug administration emerged (p N 0.05 for all
comparisons). To test for potential age differences in injection stress, al-
cohol intake on experimental day 9 (no injection) was compared to al-
cohol intake on experimental day 11 (vehicle habituation injection
30 min prior to drinking) separately within each age group. In both ad-
olescents and adults, no differences in alcohol consumption were ob-
served between days 9 and 11 (p N 0.05 for both comparisons, data
not shown.) Additionally, body weight measurements taken before
drug administration and after four days of repeated drug administration
were compared for adolescents and adults. Adolescent body weight in-
creased signiﬁcantly over days and adult body weight did not change
between measurements (Table 2), with both ages showing bodyweights similar to those reported previously (Agoglia et al., 2015)
indicating no major adverse effects of drug treatment.
3.2. Effect of CB1 inhibition on binge-like alcohol drinking
Following a 30 minute pretreatment with the CB1 receptor antago-
nist/inverse agonist AM-251, a signiﬁcant main effect of Age emerged,
F (1, 21) = 5.52, p b 0.05. A main effect of Dose was also observed, F
(3, 63) = 16.86, p b 0.0001. In adolescent mice, a planned one-way
ANOVA revealed a main effect of Dose, F (2.46) = 7.67, p b 0.01.
Holm–Sidak's multiple comparisons test revealed that the 1.0 mg/kg
,3.0 mg/kg and 10 mg/kg doses signiﬁcantly reduced alcohol consump-
tion in adolescent mice (Fig. 2A). In adult mice, an effect of Dose was
also signiﬁcant [F (2.23) = 8.87, p b 0.0001]. However, Holm–Sidak's
multiple comparisons test indicated that only the 10.0 mg/kg dose of
AM-251 signiﬁcantly reduced alcohol consumption in adult mice
(Fig. 2B) indicating age-dependent differences in dose sensitivity.
Direct comparison of adolescent intake at the lowest effective dose
(1.0 mg/kg) and adult intake under vehicle conditions failed to ﬁnd sig-
niﬁcant differences, indicating that adolescent alcohol intake had been
reduced to adult levels at this dose [t(21) = 0.086, p N 0.05].
3.3. Effect of CB1 receptor inhibition on binge-like sucrose drinking
To determine if the effects of the CB1 antagonist/inverse agonist AM-
251 were selective for alcohol consumption, or representative of effects
on other reinforcing solutions, adolescent and adult mice were
pretreated with the lowest effective dose of AM-251 (3.0 mg/kg) prior
to a four-hour sucrose consumption test. AM-251 pretreatment signiﬁ-
cantly reduced sucrose consumption in adolescent mice [t (5) = 3.30,
p b 0.05, Fig. 2C] but failed to signiﬁcantly alter sucrose drinking in
adult mice (p N 0.05, Fig. 2D). Direct comparison of adolescent sucrose
Table 2
Effect of CB1 inhibition on body weight. Mean body weight (±SEM) of adolescent (post-
natal day [PND] 34) and adult mice (PND 78) before and after administration of the CB1
antagonist/inverse agonist AM-251 (PND 42/86, respectively).
Before AM-251 After AM-251
Age (PND) Body-weight (g) Age (PND) Body-weight (g)
Adolescent 34 20.02 ± 0.28 42 22.91 ± 0.30
Adult 78 25.27 ± 0.36 86 26.72 ± 0.43
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conditions failed to ﬁnd signiﬁcant differences, indicating that adoles-
cent sucrose intake had been reduced to adult levels [t(10) = 0.34,
p N 0.05].
3.4. Effect of CB1 receptor inhibition on open-ﬁeld locomotor activity
To determine if the effects of CB1 inhibitionwith AM-251were asso-
ciated with alterations in general locomotor behavior, adolescent and
adult mice were pretreated with the lowest effective dose of AM-
251(1.0mg/kg) 30min prior to a two hour open-ﬁeld locomotor behav-
ior assay. In adolescent mice, AM-251 pretreatment failed to alter loco-
motor activity (p N 0.05, Fig. 3A). However, in adult mice AM-251
pretreatment resulted in a signiﬁcant main effect of dose, F(1,10) =
5.16, p b 0.05 (Fig. 3B), suggesting that the 1.0 mg/kg dose of AM-251
reduced locomotor activity in adults but not adolescents.
To determine whether pretreatment with AM-251 was associated
with alterations in anxiety-like behaviors, adolescent and adult mice
were evaluated for thigmotaxis during the open-ﬁeld locomotor testing.
Both adolescents (Fig. 3C) and adults (Fig. 3D) spent approximately 20%
of the session in the center of the open ﬁeld, and neither age displayed
any alterations in time spent in the center following AM-251 pretreat-
ment (p N 0.05). Additionally, a direct comparison of vehicle-treated ad-
olescent and adult mice failed to show any age differences in
thigmataxis [F (1,10) = 0.26, p N 0.05; data not shown.]Fig. 2. Effects of CB1 inhibition on binge-like alcohol and sucrose consumption. Adolescent (A) a
agonist AM-251. Adolescent (C) but not adult (D) sucrose intake was reduced by pretreatmen
multiple comparisons test/Student's t-test, * p b 0.05, *** p b 0.001.4. Discussion
The endocannabinoid CB1 receptor is the most abundant G protein-
coupled receptor in the mammalian brain (Marsicano and Lutz, 1999),
and has been shown to play a critical role in both neuronal development
(Gaffuri et al., 2012) and reward-related behaviors (Panagis et al.,
2014). However, the speciﬁc regulation of alcohol consumption by can-
nabinoid signaling during the adolescent developmental period has not
yet been reported. Here, we show that the CB1 receptor antagonist/in-
verse agonist AM-251 reduces binge-like alcohol and sucrose consump-
tion in male C57BL/6J mice. However, adolescent mice were more
sensitive than adults to this effect, displaying reductions in alcohol
and sucrose drinking following AM-251 (1 or 3 mg/kg); doses that
were ineffective at modulating intake in adults. We further report re-
duced sensitivity to the locomotor effects of AM-251 in adolescent
mice, but no age or drug differences in thigmotaxis following AM-251
pretreatment. Together, these ﬁndings provide evidence of differential
sensitivity to pharmacological manipulation of the CB1 receptor in ado-
lescent and adultmice, and point to endocannabinoid signaling as a pos-
sible mechanism for age differences in alcohol consumption.
The drinking model employed in the present experiments resulted
in signiﬁcant age differences in alcohol and sucrose consumption such
that adolescent mice consumed more alcohol g/kg and sucrose mL/kg
than adult mice. This ﬁnding is in agreement with previous reports of
greater alcohol and sucrose consumption among adolescent rodents
(Agoglia et al., 2015; Brunell and Spear, 2005; Maldonado et al.,
2008). Data from surveys of human alcohol users suggest that alcohol
use is usually initiated during adolescence, and adolescent alcohol in-
take has also been reported to be higher than adult intake using
human subjects (Courtney and Polich, 2009; Harford et al., 2005;
Johnston et al., 2012). Thus, the drinkingmethod employed in the pres-
ent studies appears to be an appropriate model of adolescent-typical
binge drinking. Although we did not assess blood alcohol levels in the
present experiments, previous reports from our lab have demonstrated
that both adolescent and adult mice achieve binge levels of bloodnd adult (B) alcohol intake was reduced by pretreatment with the CB1 antagonist/inverse
t with AM-251. Asterisks indicate signiﬁcant differences from vehicle with Holm–Sidak's
Fig. 3. Effects of CB1 inhibition onopen-ﬁeld locomotor activity. The CB1 antagonist/inverse agonist AM-251did not alter adolescent locomotor activity (A), but reduced locomotor activity
in adult mice in a time-dependentmanner (B). Insets show total distance traveled over the two-hour test period; *= p b 0.05. AM-251 pretreatment did not alter time spent in the center
of the open ﬁeld in either adolescents or adults (C and D).
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(Agoglia et al., 2015; Holstein et al., 2011).
Pretreatment with the CB1 antagonist /inverse agonist AM-251 sug-
gested increased sensitivity to cannabinoidmodulation in adolescent as
compared to adult mice, with all doses tested (1, 3 and 10 mg/kg) re-
ducing alcohol consumption in adolescents, whereas only the high
dose (10 mg/kg) reduced alcohol consumption in adults. Adolescent al-
cohol consumptionwas reduced by 28%, from 5.4 g/kg to 3.9 g/kg, at the
1 mg/kg dose. Notably, this reduction in alcohol consumption brought
adolescent intake to the level of untreated adult mice, who averaged
4.1 g/kg under vehicle conditions. The effect at this dose appears to be
selective for the excessive alcohol consumption exhibited by adoles-
cents, as adult alcohol intake was not signiﬁcantly reduced at this
dose. Adolescent sucrose consumption was also reduced to adult levels
after pretreatment with the 3 mg/kg dose of AM-251. Adolescent su-
crose intake decreased from 131.1 mL/kg under vehicle conditions to
97.6 mL/kg after 3 mg/kg of AM-251, putting adolescent intake in line
with average adult sucrose intake (90.2 mL/kg). Consistent with the al-
cohol experiments, 3 mg/kg AM-251 did not signiﬁcantly reduce adult
sucrose consumption. Thus, inhibition of the CB1 receptor with AM-
251 appears to blunt the adolescent-typical phenotype of increased
binge alcohol and sucrose drinking and bring adolescent consumption
to a more moderate adult-like level. This ﬁnding points to activity of
the CB1 receptor as amediator of the increased alcohol and sucrose con-
sumption typically displayed by adolescents as compared to adults.
Decreases in alcohol consumption may also be due to alterations in
alcohol metabolism as a result of AM-251 treatment. We did not assess
blood alcohol concentration in the present experiments, nor have any
previous studies determined the effects of AM-251 on alcohol
metabolism. However, the CB1 receptor inverse agonist/antagonist
SR141716A has a similar mechanism of action as AM-251 and induces
similar decreases in alcohol consumption. Previous studies have foundthat SR141716A pretreatment does not alter blood alcohol concentra-
tion in rats (Lallemand et al., 2001; Serra et al., 2001). These previous re-
ports make actions of AM-251 on alcohol metabolism less likely.
However, in future studies it will be important to assess blood alcohol
levels with and without AM-251 pretreatment to deﬁnitively address
this question.
Adult mice displayed a reduction in open-ﬁeld locomotor activity
following pretreatment with 1.0 mg/kg AM-251. Therefore, the reduc-
tion in adult alcohol consumption at the 10 mg/kg dose should be con-
sidered in light of potential gross locomotor effects and not speciﬁc
effects on alcohol drinking. In contrast, adolescent mice did not show
any effect of AM-251 pretreatment on open-ﬁeld locomotor activity.
Thisﬁnding indicates additional age differences in the behavioral effects
of CB1 receptor inhibition, as adolescents appear to have reduced sensi-
tivity to the locomotor effects of AM-251. Additionally, modulation of
CB1 activity has been shown to alter anxiety-related behaviors, and
age differences in sensitivity to the anxiogenic effects of CB1 activation
in adolescents and adults have been reported (Klugmann et al., 2011).
The current experiments failed to detect any effect of AM-251 on thig-
motaxis in either adolescents or adults. This result suggests that the
age differences in the effects of AM-251 on alcohol and sucrose con-
sumption are likely independent of any anxiety-related effect of this
drug as measured by the open-ﬁeld thigmotaxy assay. Injection itself
is a potential stressor, and adolescents have been shown to bemore sen-
sitive to some stressors than adults (Spear, 2000). We therefore com-
pared adolescent and adult alcohol intake on a day without injections
(experimental day 9) and a day with vehicle injection prior to drinking
(experimental day 11). No differences in alcohol intake between days
emerged in either age group, suggesting that injection stress was not
signiﬁcantly different between ages. Additionally, we compared adoles-
cent and adult mice treated with vehicle injections directly in the open-
ﬁeld locomotor activity assay. No age differences in thigmataxis
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like behavior than adults after injection.
The effects of the CB1 antagonist/inverse agonist AM-251 on alcohol
drinking reported here are reminiscent of those observed byWang et al.
(2003), who found that pretreatment with the CB1 antagonist/inverse
agonist SR141716A reduced alcohol consumption in young adults but
not oldermice. Further, in the present study, adolescents were sensitive
to anAM-251-induced decrease in sucrose consumptionwhereas adults
showed no effect of AM-251 pretreatment, indicating that the effects of
CB1 inhibition in adolescents reduced consumption of reinforcing solu-
tions generally. The relationship between age differences in behavioral
effects of CB1 inhibition and the altered expression of the CB1 receptor
in the adolescent brain remains unclear. Adolescents display increased
CB1 receptor expression, which may reduce sensitivity to CB1 modula-
tion owing to the greater number of receptors needed to be occupied
achieve a signiﬁcant proportion of activation; i.e. a higher dose of AM-
251 would be predicted to be necessary in adolescents to reach behav-
ioral signiﬁcance. In contrast, we observed increased behavioral sensi-
tivity of adolescent mice to CB1 inhibition, which may be explained by
receptor “spareness”, or increased efﬁcacy of the compound in adoles-
cent mice, leading to behavioral effects despite a smaller proportion of
occupied receptors (Rang, 2006). The underlying biology of the adoles-
cent endocannabinoid system contributing to this increased sensitivity
to AM-251 is likewise unknown. However, adolescent mice have been
shown to have altered functional coupling between the CB1 receptor
and G proteins as compared with adult mice (Moore et al., 2010;
Wang et al., 2003), which is a plausible explanation for age differences
in sensitivity to CB1 inhibition. Although previous reports have shown
that G protein expression reaches adult levels in the mouse cortex by
PND 25 (Ihnatovych et al., 2002), age differences in CB1 receptor traf-
ﬁcking to the plasma membrane or the inﬂuence of CB1 accessory pro-
teins could explain differences in functional coupling of CB1 in
adolescents and adults. Direct manipulation of the CB1 receptor in the
adolescent brain using genetic or pharmacological strategies would
help to clarify the molecular mechanism driving the age differences in
sensitivity to CB1 antagonism/inverse agonism.
The CB1 receptor is involved in appetite and consummatory behav-
iors (Jager andWitkamp, 2014), and previous studies have reported de-
creases in body weight following pretreatment with the cannabinoid
antagonist/inverse agonist AM-251 (Merroun et al., 2013). The within-
subjects design of the present studiesmade drug effects on bodyweight
more difﬁcult to detect, owing to the lack of completely untreated mice
for comparison. However, body weights of adolescent and adult mice
were compared prior to drug treatment and after four days of repeated
administration of AM-251. Adolescent body weight increased in a nor-
mal developmental trajectory (Agoglia et al., 2015), and adult body
weight remained unchanged before and after treatment with either
drug. The relatively short exposure period and lower doses used in the
present experiments do not appear to alter body weight in adolescent
or adult mice. We also did not observe gross developmental defects in
adolescent mice treated with AM-251 as indexed by normal body
weight and locomotor activity in an open ﬁeld.
In summary, the current study provides evidence of altered behav-
ioral sensitivity to pharmacological inhibition of the CB1 receptor in ad-
olescent mice. Administration of the CB1 antagonist/inverse agonist
AM-251 reduced binge alcohol and sucrose consumption in both ado-
lescent and adult mice. However, adolescent alcohol and sucrose con-
sumption were reduced at all doses tested, and intake of both
solutions decreased to adult levels. Adult alcohol and sucrose intake
were reduced only at the highest dose, and adults displayed reductions
in locomotor activity absent in adolescentmice. These experiments pro-
vide new evidence for age differences in the behavioral pharmacology
of the CB1 signaling systems, which may be due to well-characterized
alterations in the CB1 systems during adolescent brain development.
Further, these ﬁndings point to developmental differences in CB1 sig-
naling as a potential regulator of age differences in the consumption ofreinforcing solutions. Mechanistic studies aimed at the brain regions re-
sponsible for these age differences and the long-term consequences of
adolescent alcohol exposure would deﬁnitively establish a role for can-
nabinoid signaling in the adolescent brain on alcohol.
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